BioSpace News Archive

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) announces four projects selected to receive support directed towards improving the quality of care for advanced ovarian cancer patients

The Maryland Tech Council has announced the finalists for its annual Industry Awards Celebration.

Cutting-edge therapies for depression are currently in high demand. Depression affects more than 264 million people worldwide. “Spravato” is the latest technique being utilized to counteract treatment-resistant depression

Model N, Inc., the leader in cloud revenue management solutions, announced Rainmaker20 LIVE, a virtual event that empowers Model N customers to “know and grow” their top line revenue.

rMark Bio, a leader in the application of AI to accelerate innovation, collaboration, and scientific discovery for life sciences, and West Monroe Partners, a national business and technology consultancy, today announced the formation of the industry’s first Medical Affairs Artificial Intelligence Center of Excellence (CoE) focused on supporting transformation within life science organizations

The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products.

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its VITROS® B•R•A•H•M•S PCT (Procalcitonin) assay to help clinicians identify sepsis and other severe bacterial infections.

The U.S. Food and Drug Administration today issued a new draft guidance, “Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control,” to solicit public comment on its proposals for broad safety evaluations before drug approval that look beyond ischemic (reduced blood flow) cardiovascular disease, as

CENTOGENE (Nasdaq: CNTG) ─ The Company today announced that Dr. Dirk H. Ehlers, COO and President of its Clinical Diagnostics Division, has decided to step down from his role after the Annual General Meeting in June 2020 and leave the Company for personal reasons

Sirnaomics Inc., today announced that the company’s abstract related to preclinical data for lead product candidate STP705 in human squamous carcinoma model has been accepted as an online ePoster for the 2020 American Academy of Dermatology (AAD) Annual Meeting that is being held March 20-24 in Denver, CO.